Biomarkers to direct treatment of Dengue fever patients

Project 66

Problem to be solved:
• Difficulties in treating patients with dengue fever
• Clinical features evolving into hemorrhagic dengue fever
• Absence of product to predict hemorrhagic dengue fever

Proposed Innovation:
• Characterization of biomarkers for hemorrhagic dengue fever
• Identification of genetic predisposition to develop severe forms of the disease
• Kit to predict the development of hemorrhagic dengue fever

Differential:
• Specific and preventive treatment against the disease
• Correct prognosis for over 95% of patients
• Reduction in mortality
• Reduction in treatment cost and hospitalization

Development status:
Prototype

Intellectual property status:
BRPI0903187-1

What we want
Partnership

Coordinator:
Ernesto Torres de Azevedo Marques Jr. / CPqAM

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br